Showing results (461-470 of 585) with videos related to

Sort By:
Pageof 59
Lung Cancer (Amsterdam, Netherlands)|January 24, 2012
Maintenance treatment of advanced non-small-cell lung cancer: results of an international expert panel meeting of the Italian association of thoracic oncologyCesare Gridelli, Filippo de Marinis, Massimo Di Maio, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 2, 2008
Second-line treatment of advanced non-small cell lung cancerCesare Gridelli, Andrea Ardizzoni, Fortunato Ciardiello, et al.
Revista Da Sociedade Brasileira De Medicina Tropical|December 19, 2025
Evaluation of T-NGS, Xpert Ultra, and Line Probe Assay on Clinical Samples for the Diagnosis of Drug-Resistant Pulmonary Tuberculosis in Rio de JaneiroMarcela Bhering, Eunice Petris Ribeiro, Anna Karla Silveira, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
Exosomal RNA-profiling of pleural effusions identifies adenocarcinoma patients through elevated miR-200 and LCN2 expressionPer Hydbring, Luigi De Petris, Yanming Zhang, et al.
Metallomics : Integrated Biometal Science|June 30, 2023
Regulation of Atp7a RNA contributes to differentiation-dependent Cu redistribution in skeletal muscle cellsThomas J Whitlow, Yu Zhang, Nathan Ferguson, et al.
Molecular Neurobiology|November 7, 2013
Loss of P2Y₂ nucleotide receptors enhances early pathology in the TgCRND8 mouse model of Alzheimer's diseaseDeepa Ajit, Lucas T Woods, Jean M Camden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005
Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panelCesare Gridelli, Matti Aapro, Andrea Ardizzoni, et al.
Translational Lung Cancer Research|November 17, 2022
Plasma RNA profiling unveils transcriptional signatures associated with resistance to osimertinib in EGFR T790M positive non-small cell lung cancer patientsAndrey Alexeyenko, Odd Terje Brustugun, Inger Johanne Zwicky Eide, et al.
Journal of Personalized Medicine|December 23, 2022
The Value of Early and Follow-Up Elevated Scores Based on Peripheral Complete Blood Cell Count for Predicting Adverse Outcomes in COVID-19 PatientsAndrei-Costin Chelariu, Adorata Elena Coman, Catalina Lionte, et al.
Pageof 59